TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 46 filers reported holding TG THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $198 | -99.8% | 8,000 | -70.3% | 0.00% | 0.0% |
| Q2 2022 | $114,000 | -45.7% | 26,900 | +21.7% | 0.00% | 0.0% |
| Q1 2022 | $210,000 | -49.9% | 22,100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $419,000 | -45.4% | 22,100 | -4.3% | 0.00% | -66.7% |
| Q3 2021 | $768,000 | -24.4% | 23,100 | -11.8% | 0.00% | -25.0% |
| Q2 2021 | $1,016,000 | -37.1% | 26,200 | -21.8% | 0.00% | -33.3% |
| Q1 2021 | $1,614,000 | +39.9% | 33,500 | +50.9% | 0.01% | +50.0% |
| Q4 2020 | $1,154,000 | +176.7% | 22,200 | +42.3% | 0.00% | +100.0% |
| Q3 2020 | $417,000 | +358.2% | 15,600 | +231.9% | 0.00% | – |
| Q2 2020 | $91,000 | -62.7% | 4,700 | -79.4% | 0.00% | -100.0% |
| Q3 2014 | $244,000 | +388.0% | 22,800 | +330.2% | 0.00% | – |
| Q2 2014 | $50,000 | +35.1% | 5,300 | 0.0% | 0.00% | – |
| Q1 2014 | $37,000 | +76.2% | 5,300 | 0.0% | 0.00% | – |
| Q4 2013 | $21,000 | -30.0% | 5,300 | -10.2% | 0.00% | – |
| Q3 2013 | $30,000 | -21.1% | 5,900 | 0.0% | 0.00% | – |
| Q2 2013 | $38,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |